Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 01, 2021

SELL
$212.27 - $248.7 $1.46 Million - $1.71 Million
-6,893 Closed
0 $0
Q2 2021

Aug 03, 2021

BUY
$233.58 - $259.14 $115,622 - $128,274
495 Added 7.74%
6,893 $1.68 Million
Q1 2021

Apr 29, 2021

BUY
$221.91 - $258.6 $6,879 - $8,016
31 Added 0.49%
6,398 $1.59 Million
Q4 2020

Feb 02, 2021

SELL
$216.38 - $257.67 $834,577 - $993,833
-3,857 Reduced 37.72%
6,367 $1.46 Million
Q3 2020

Nov 06, 2020

SELL
$234.65 - $260.95 $777,864 - $865,049
-3,315 Reduced 24.48%
10,224 $2.6 Million
Q2 2020

Jul 23, 2020

SELL
$197.81 - $242.74 $1.18 Million - $1.45 Million
-5,975 Reduced 30.62%
13,539 $3.19 Million
Q1 2020

Apr 30, 2020

BUY
$182.24 - $241.7 $7,471 - $9,909
41 Added 0.21%
19,514 $3.96 Million
Q4 2019

Jan 28, 2020

SELL
$189.21 - $243.2 $155,152 - $199,424
-820 Reduced 4.04%
19,473 $4.69 Million
Q3 2019

Nov 01, 2019

BUY
$174.11 - $208.62 $297,902 - $356,948
1,711 Added 9.21%
20,293 $3.93 Million
Q2 2019

Aug 01, 2019

BUY
$166.7 - $195.41 $19,670 - $23,058
118 Added 0.64%
18,582 $3.42 Million
Q1 2019

Apr 24, 2019

SELL
$180.87 - $203.88 $266,964 - $300,926
-1,476 Reduced 7.4%
18,464 $3.51 Million
Q4 2018

Feb 01, 2019

BUY
$178.4 - $208.25 $104,720 - $122,242
587 Added 3.03%
19,940 $3.88 Million
Q3 2018

Oct 25, 2018

SELL
$185.29 - $208.89 $185 - $208
-1 Reduced 0.01%
19,353 $4.01 Million
Q2 2018

Aug 02, 2018

SELL
$166.05 - $186.51 $90,331 - $101,461
-544 Reduced 2.73%
19,354 $3.57 Million
Q1 2018

Apr 25, 2018

SELL
$169.43 - $198.0 $197,894 - $231,264
-1,168 Reduced 5.54%
19,898 $3.39 Million
Q4 2017

Jan 30, 2018

BUY
$168.79 - $188.59 $101,949 - $113,908
604 Added 2.95%
21,066 $3.66 Million
Q3 2017

Oct 30, 2017

BUY
$167.29 - $191.0 $3.42 Million - $3.91 Million
20,462
20,462 $3.82 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Wright Investors Service Inc Portfolio

Follow Wright Investors Service Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wright Investors Service Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wright Investors Service Inc with notifications on news.